NCT00362258View on ClinicalTrials.gov

I PREVENT - Irbesartan In Hypertensive Diabetic Patients

PHASE4CompletedINTERVENTIONAL

Enrollment

797

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Hypertension

Interventions

DRUG

Irbesartan (Aprovel)

Aprovel (150 \& 300mg) \& CoAprovel (300/12.5mg hydrochlorothiazide) one tablet/day per os.

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Cairo

Sponsors

Lead Sponsor

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Sanofi

INDUSTRY